{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T14:22:07Z","timestamp":1791555727345,"version":"4.3.4"},"reference-count":116,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["ES026892"],"award-info":[{"award-number":["ES026892"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["ES027245"],"award-info":[{"award-number":["ES027245"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS088206"],"award-info":[{"award-number":["NS088206"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS100090"],"award-info":[{"award-number":["NS100090"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.expneurol.2021.113716","type":"journal-article","created":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T12:14:21Z","timestamp":1617884061000},"page":"113716","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Characterization of nonmotor behavioral impairments and their neurochemical mechanisms in the MitoPark mouse model of progressive neurodegeneration in Parkinson's disease"],"prefix":"10.1016","volume":"341","author":[{"given":"Monica R.","family":"Langley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivani","family":"Ghaisas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bharathi N.","family":"Palanisamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammet","family":"Ay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huajun","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vellareddy","family":"Anantharam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthi","family":"Kanthasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anumantha G.","family":"Kanthasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2021.113716_bb0005","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1212\/01.wnl.0000183056.89590.0d","article-title":"Excessive daytime sleepiness and subsequent development of Parkinson disease","volume":"65","author":"Abbott","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2021.113716_bb0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0125470","article-title":"Unexpected dual task benefits on cycling in Parkinson disease and healthy adults: a neuro-behavioral model","volume":"10","author":"Altmann","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2021.113716_bb0015","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.expneurol.2007.05.010","article-title":"Loss of enteric dopaminergic neurons and associated changes in colon motility in an MPTP mouse model of Parkinson\u2019s disease","volume":"207","author":"Anderson","year":"2007","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2021.113716_bb0020","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/jnc.14033","article-title":"Molecular mechanisms underlying protective effects of quercetin against mitochondrial dysfunction and progressive dopaminergic neurodegeneration in cell culture and MitoPark transgenic mouse models of Parkinson\u2019s disease","volume":"141","author":"Ay","year":"2017","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2021.113716_bb0025","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jns.2016.12.060","article-title":"Neuropsychiatric symptoms, behavioural disorders, and quality of life in Parkinson\u2019s disease","volume":"373","author":"Balestrino","year":"2017","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.expneurol.2021.113716_bb0030","doi-asserted-by":"crossref","first-page":"3975101","DOI":"10.1155\/2016\/3975101","article-title":"Oxidative stress implications in the affective disorders: Main biomarkers, animal models relevance, genetic perspectives, and antioxidant approaches","volume":"2016","author":"Balmus","year":"2016","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.expneurol.2021.113716_bb0035","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1002\/syn.20451","article-title":"The number of dopaminergic cells is increased in the olfactory bulb of monkeys chronically exposed to MPTP","volume":"61","author":"Belzunegui","year":"2007","journal-title":"Synapse"},{"key":"10.1016\/j.expneurol.2021.113716_bb0040","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s10072-010-0403-5","article-title":"Protracted benefit from paradoxical kinesia in typical and atypical parkinsonisms","volume":"31","author":"Bonanni","year":"2010","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.expneurol.2021.113716_bb0045","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3389\/fnbeh.2014.00290","article-title":"A mouse model of non-motor symptoms in Parkinson\u2019s disease: focus on pharmacological interventions targeting affective dysfunctions","volume":"8","author":"Bonito-Oliva","year":"2014","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.expneurol.2021.113716_bb0050","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.biopsych.2013.02.015","article-title":"Cognitive impairment and dentate gyrus synaptic dysfunction in experimental parkinsonism","volume":"75","author":"Bonito-Oliva","year":"2014","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.expneurol.2021.113716_bb0055","doi-asserted-by":"crossref","first-page":"4026","DOI":"10.1523\/JNEUROSCI.1395-15.2016","article-title":"Dopaminergic neurons exhibit an age-dependent decline in electrophysiological parameters in the MitoPark mouse model of Parkinson\u2019s disease","volume":"36","author":"Branch","year":"2016","journal-title":"J. Neurosci."},{"issue":"53","key":"10.1016\/j.expneurol.2021.113716_bb0060","first-page":"e2920","article-title":"Morris water maze test for learning and memory deficits in alzheimer\u2019s disease model mice","author":"Bromley-Brits","year":"2011","journal-title":"J. Visual. Exper."},{"key":"10.1016\/j.expneurol.2021.113716_bb0065","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/ana.21541","article-title":"A critical evaluation of the Braak staging scheme for Parkinson\u2019s disease","volume":"64","author":"Burke","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2021.113716_bb0070","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3389\/fnbeh.2013.00175","article-title":"Rodent models of Parkinson\u2019s disease: beyond the motor symptomatology","volume":"7","author":"Campos","year":"2013","journal-title":"Front. Behav. Neurosci."},{"issue":"59","key":"10.1016\/j.expneurol.2021.113716_bb0075","doi-asserted-by":"crossref","DOI":"10.3791\/3638-v","article-title":"The mouse forced swim test","author":"Can","year":"2012","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.expneurol.2021.113716_bb0080","first-page":"e3769","article-title":"The tail suspension test","author":"Can","year":"2012","journal-title":"J. Visual. Exp."},{"key":"10.1016\/j.expneurol.2021.113716_bb0085","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.smrv.2016.08.001","article-title":"A systematic review of the literature on disorders of sleep and wakefulness in Parkinson\u2019s disease from 2005 to 2015","volume":"35","author":"Chahine","year":"2017","journal-title":"Sleep Med. Rev."},{"key":"10.1016\/j.expneurol.2021.113716_bb0090","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S1474-4422(09)70068-7","article-title":"Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment","volume":"8","author":"Chaudhuri","year":"2009","journal-title":"The Lancet. Neurology"},{"key":"10.1016\/j.expneurol.2021.113716_bb0095","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.neuropsychologia.2015.10.036","article-title":"Visuomotor control in patients with Parkinson's disease","volume":"80","author":"Chen","year":"2016","journal-title":"Neuropsychologia"},{"key":"10.1016\/j.expneurol.2021.113716_bb0100","first-page":"20","article-title":"Delayed dopamine dysfunction and motor deficits in female parkinson model mice","author":"Chen","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.expneurol.2021.113716_bb0105","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.neuropharm.2015.03.020","article-title":"Long-term treatment with L-DOPA or pramipexole affects adult neurogenesis and corresponding non-motor behavior in a mouse model of Parkinson's disease","volume":"95","author":"Chiu","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.expneurol.2021.113716_bb0110","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.fct.2013.05.007","article-title":"Cognitive-enhancing effects of Rhus verniciflua bark extract and its active flavonoids with neuroprotective and anti-inflammatory activities","volume":"58","author":"Cho","year":"2013","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.expneurol.2021.113716_bb0115","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1021\/acschemneuro.7b00042","article-title":"The rodent forced swim test measures stress-coping strategy, not depression-like behavior","volume":"8","author":"Commons","year":"2017","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.expneurol.2021.113716_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151884","article-title":"Multimodal MRI evaluation of the MitoPark mouse model of Parkinson\u2019s disease","volume":"11","author":"Cong","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2021.113716_bb0125","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.neuron.2008.03.001","article-title":"Behavioral phenotyping strategies for mutant mice","volume":"57","author":"Crawley","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2021.113716_bb0130","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.expneurol.2015.02.012","article-title":"Conditional genetic deletion of PTEN after a spinal cord injury enhances regenerative growth of CST axons and motor function recovery in mice","volume":"266","author":"Danilov","year":"2015","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2021.113716_bb0135","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.neuron.2010.04.034","article-title":"Genetic animal models of Parkinson's disease","volume":"66","author":"Dawson","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2021.113716_bb0140","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/j.1749-6632.2009.03926.x","article-title":"Symposium overview: do environmental agents enter the brain via the olfactory mucosa to induce neurodegenerative diseases?","volume":"1170","author":"Doty","year":"2009","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.expneurol.2021.113716_bb0145","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nrneurol.2012.80","article-title":"Olfactory dysfunction in Parkinson disease","volume":"8","author":"Doty","year":"2012","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.expneurol.2021.113716_bb0150","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/ana.410320116","article-title":"Lack of major olfactory dysfunction in MPTP-induced parkinsonism","volume":"32","author":"Doty","year":"1992","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2021.113716_bb0155","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.neulet.2014.09.042","article-title":"A novel mitochondrially-targeted apocynin derivative prevents hyposmia and loss of motor function in the leucine-rich repeat kinase 2 (LRRK2(R1441G)) transgenic mouse model of Parkinson\u2019s disease","volume":"583","author":"Dranka","year":"2014","journal-title":"Neurosci. Lett."},{"issue":"Suppl. 3","key":"10.1016\/j.expneurol.2021.113716_bb0160","doi-asserted-by":"crossref","first-page":"S185","DOI":"10.1016\/S1353-8020(09)70811-9","article-title":"The MitoPark mouse - an animal model of Parkinson\u2019s disease with impaired respiratory chain function in dopamine neurons","volume":"15","author":"Ekstrand","year":"2009","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.expneurol.2021.113716_bb0165","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1073\/pnas.0605208103","article-title":"Progressive parkinsonism in mice with respiratory-chain-deficient dopamine neurons","volume":"104","author":"Ekstrand","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2021.113716_bb0170","article-title":"Manganese: its role in disease and health","volume":"19","author":"Erikson","year":"2019","journal-title":"Metal Ion Life Sci."},{"key":"10.1016\/j.expneurol.2021.113716_bb0175","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.neubiorev.2018.10.004","article-title":"The hidden side of Parkinson\u2019s disease: studying pain, anxiety and depression in animal models","volume":"96","author":"Faivre","year":"2019","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.expneurol.2021.113716_bb0180","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.brainres.2016.09.025","article-title":"Altered glutamate release in the dorsal striatum of the MitoPark mouse model of Parkinson\u2019s disease","volume":"1651","author":"Farrand","year":"2016","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2021.113716_bb0185","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.nbd.2011.10.019","article-title":"Neurochemistry and the non-motor aspects of PD","volume":"46","author":"Ferrer","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2021.113716_bb0190","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.nbd.2014.08.024","article-title":"Loss of dopamine disrupts circadian rhythms in a mouse model of Parkinson\u2019s disease","volume":"71","author":"Fifel","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2021.113716_bb0195","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1460-9568.2008.06346.x","article-title":"Olfactory deficits in mice overexpressing human wildtype alpha-synuclein","volume":"28","author":"Fleming","year":"2008","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.expneurol.2021.113716_bb0200","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/toxsci\/kfw007","article-title":"Aberrant adult neurogenesis in the subventricular zone-rostral migratory stream-olfactory bulb system following subchronic manganese exposure","volume":"150","author":"Fu","year":"2016","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.expneurol.2021.113716_bb0205","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1600-0404.2009.01253.x","article-title":"Brain-derived neurotrophic factor G196A polymorphism and clinical features in Parkinson\u2019s disease","volume":"122","author":"Gao","year":"2010","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.expneurol.2021.113716_bb0210","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.neuro.2019.09.004","article-title":"MitoPark transgenic mouse model recapitulates the gastrointestinal dysfunction and gut-microbiome changes of Parkinson's disease","volume":"75","author":"Ghaisas","year":"2019","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.expneurol.2021.113716_bb0215","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/1742-2094-9-241","article-title":"Anti-inflammatory and neuroprotective effects of an orally active apocynin derivative in pre-clinical models of Parkinson\u2019s disease","volume":"9","author":"Ghosh","year":"2012","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.expneurol.2021.113716_bb0220","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s11481-016-9650-4","article-title":"Mitoapocynin treatment protects against Neuroinflammation and dopaminergic Neurodegeneration in a preclinical animal model of Parkinson\u2019s disease","volume":"11","author":"Ghosh","year":"2016","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.expneurol.2021.113716_bb0225","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41531-018-0055-3","article-title":"Cognitive impairment in Parkinson's disease: a report from a multidisciplinary symposium on unmet needs and future directions to maintain cognitive health","volume":"4","author":"Goldman","year":"2018","journal-title":"NPJ Parkinsons Dis"},{"key":"10.1016\/j.expneurol.2021.113716_bb0230","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1096\/fj.10-173625","article-title":"Impaired nigrostriatal function precedes behavioral deficits in a genetic mitochondrial model of Parkinson\u2019s disease","volume":"25","author":"Good","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.expneurol.2021.113716_bb0235","doi-asserted-by":"crossref","first-page":"12932","DOI":"10.1038\/ncomms12932","article-title":"Prokineticin-2 upregulation during neuronal injury mediates a compensatory protective response against dopaminergic neuronal degeneration","volume":"7","author":"Gordon","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.expneurol.2021.113716_bb0240","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.neuroimage.2015.09.021","article-title":"Challenges in the reproducibility of clinical studies with resting state fMRI: an example in early Parkinson\u2019s disease","volume":"124","author":"Griffanti","year":"2016","journal-title":"Neuroimage"},{"key":"10.1016\/j.expneurol.2021.113716_bb0245","first-page":"450939","article-title":"Olfactory loss in Parkinson's disease","volume":"2011","author":"Haehner","year":"2011","journal-title":"Parkinson's Dis."},{"key":"10.1016\/j.expneurol.2021.113716_bb0250","doi-asserted-by":"crossref","first-page":"654","DOI":"10.3389\/fnins.2019.00654","article-title":"Manganese-induced neurotoxicity: new insights into the triad of protein Misfolding, mitochondrial impairment, and Neuroinflammation","volume":"13","author":"Harischandra","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.expneurol.2021.113716_bb0255","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.bbr.2008.10.015","article-title":"Endogenous anxiety and stress responses in water maze and Barnes maze spatial memory tasks","volume":"198","author":"Harrison","year":"2009","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.expneurol.2021.113716_bb0260","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.bandc.2017.01.002","article-title":"Improved cognition while cycling in Parkinson\u2019s disease patients and healthy adults","volume":"113","author":"Hazamy","year":"2017","journal-title":"Brain Cogn."},{"key":"10.1016\/j.expneurol.2021.113716_bb0265","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1146\/annurev-nutr-071714-034419","article-title":"Manganese is essential for neuronal health","volume":"35","author":"Horning","year":"2015","journal-title":"Annu. Rev. Nutr."},{"key":"10.1016\/j.expneurol.2021.113716_bb0270","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1002\/mds.22009","article-title":"Gender-related changes in increase of dopaminergic neurons in the olfactory bulb of Parkinson\u2019s disease patients","volume":"23","author":"Huisman","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2021.113716_bb0275","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1002\/mds.20980","article-title":"What is the evidence for a premorbid parkinsonian personality: a systematic review","volume":"21","author":"Ishihara","year":"2006","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2021.113716_bb0280","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/01616412.2016.1251711","article-title":"Oxidative stress and mitochondrial dysfunction-linked neurodegenerative disorders","volume":"39","author":"Islam","year":"2017","journal-title":"Neurol. Res."},{"key":"10.1016\/j.expneurol.2021.113716_bb0285","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1159\/000197890","article-title":"Significance of brain lesions in Parkinson disease dementia and Lewy body dementia","volume":"24","author":"Jellinger","year":"2009","journal-title":"Front. Neurol. Neurosci."},{"key":"10.1016\/j.expneurol.2021.113716_bb0290","doi-asserted-by":"crossref","first-page":"19840","DOI":"10.1074\/jbc.M110.203687","article-title":"Transcriptional regulation of pro-apoptotic protein kinase Cdelta: implications for oxidative stress-induced neuronal cell death","volume":"286","author":"Jin","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2021.113716_bb0295","doi-asserted-by":"crossref","first-page":"34743","DOI":"10.1074\/jbc.M114.576702","article-title":"Histone hyperacetylation up-regulates protein kinase Cdelta in dopaminergic neurons to induce cell death: relevance to epigenetic mechanisms of neurodegeneration in Parkinson disease","volume":"289","author":"Jin","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2021.113716_bb0300","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jns.2016.07.057","article-title":"The combined effect of REM sleep behavior disorder and hyposmia on cognition and motor phenotype in Parkinson\u2019s disease","volume":"368","author":"Kang","year":"2016","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.expneurol.2021.113716_bb0305","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.neuro.2009.12.003","article-title":"Novel cell death signaling pathways in neurotoxicity models of dopaminergic degeneration: relevance to oxidative stress and neuroinflammation in Parkinson's disease","volume":"31","author":"Kanthasamy","year":"2010","journal-title":"Neurotoxicology"},{"issue":"22","key":"10.1016\/j.expneurol.2021.113716_bb0310","first-page":"e1088","article-title":"Elevated plus Maze for Mice","author":"Komada","year":"2008","journal-title":"J. Visual. Exp."},{"key":"10.1016\/j.expneurol.2021.113716_bb0315","doi-asserted-by":"crossref","first-page":"113159","DOI":"10.1016\/j.expneurol.2019.113159","article-title":"Alterations of the gut microbiota with antibiotics protects dopamine neuron loss and improve motor deficits in a pharmacological rodent model of Parkinson\u2019s disease","volume":"325","author":"Koutzoumis","year":"2020","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2021.113716_bb0320","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/nature07455","article-title":"The molecular neurobiology of depression","volume":"455","author":"Krishnan","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2021.113716_bb0325","doi-asserted-by":"crossref","first-page":"808643","DOI":"10.1155\/2014\/808643","article-title":"Environmental control of adult neurogenesis: from hippocampal homeostasis to behavior and disease","volume":"2014","author":"Kuipers","year":"2014","journal-title":"Neural Plast."},{"key":"10.1016\/j.expneurol.2021.113716_bb0330","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0077509","article-title":"Olfaction in three genetic and two MPTP-induced Parkinson\u2019s disease mouse models","volume":"8","author":"Kurtenbach","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2021.113716_bb0335","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1002\/cne.23607","article-title":"Harnessing neurogenesis for the possible treatment of Parkinson\u2019s disease","volume":"522","author":"Lamm","year":"2014","journal-title":"J. Comp. Neurol."},{"issue":"14","key":"10.1016\/j.expneurol.2021.113716_bb0340","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1089\/ars.2016.6905","article-title":"Mito-Apocynin prevents mitochondrial dysfunction, microglial activation, oxidative damage, and progressive Neurodegeneration in MitoPark transgenic mice","volume":"27","author":"Langley","year":"2017","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.expneurol.2021.113716_bb0345","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.neuro.2017.06.002","article-title":"Manganese exposure exacerbates progressive motor deficits and neurodegeneration in the MitoPark mouse model of Parkinson\u2019s disease: relevance to gene and environment interactions in metal neurotoxicity","volume":"64","author":"Langley","year":"2018","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.expneurol.2021.113716_bb0350","doi-asserted-by":"crossref","first-page":"9651","DOI":"10.1038\/srep09651","article-title":"Hippocampal memory enhancing activity of pine needle extract against scopolamine-induced amnesia in a mouse model","volume":"5","author":"Lee","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.expneurol.2021.113716_bb0355","first-page":"987084","article-title":"Effects of human alpha-Synuclein A53T-A30P mutations on SVZ and local olfactory bulb cell proliferation in a transgenic rat model of Parkinson disease","volume":"2011","author":"Lelan","year":"2011","journal-title":"Parkinson\u2019s Dis."},{"key":"10.1016\/j.expneurol.2021.113716_bb0360","article-title":"Cognitive dysfunction precedes the onset of motor symptoms in the MitoPark mouse model of Parkinson\u2019s disease","volume":"8","author":"Li","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2021.113716_bb0365","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047387","article-title":"Non-motor symptoms in patients with Parkinson\u2019s disease - correlations with inflammatory cytokines in serum","volume":"7","author":"Lindqvist","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2021.113716_bb0370","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/BF00177912","article-title":"The use of a plus-maze to measure anxiety in the mouse","volume":"92","author":"Lister","year":"1987","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.expneurol.2021.113716_bb0375","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/j.neuroscience.2009.09.025","article-title":"Interferon-gamma deficiency modifies the motor and co-morbid behavioral pathology and neurochemical changes provoked by the pesticide paraquat","volume":"164","author":"Litteljohn","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2021.113716_bb0380","doi-asserted-by":"crossref","first-page":"669","DOI":"10.3233\/JPD-140503","article-title":"Social cognition impairments in mice overexpressing alpha-Synuclein under the Thy1 promoter, a model of pre-manifest Parkinson\u2019s disease","volume":"5","author":"Magen","year":"2015","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.expneurol.2021.113716_bb0385","doi-asserted-by":"crossref","first-page":"681","DOI":"10.3233\/JPD-150685","article-title":"The concept of prodromal Parkinson\u2019s disease","volume":"5","author":"Mahlknecht","year":"2015","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.expneurol.2021.113716_bb0390","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S1474-4422(18)30127-3","article-title":"Risk factors for non-motor symptoms in Parkinson\u2019s disease","volume":"17","author":"Marinus","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.expneurol.2021.113716_bb0395","first-page":"474","article-title":"The role of inflammatory cytokines in cognition and other non-motor symptoms of Parkinson's disease","volume":"51","author":"Menza","year":"2010","journal-title":"Psychosomatics"},{"key":"10.1016\/j.expneurol.2021.113716_bb0400","first-page":"350","article-title":"Apathy in Parkinson\u2019s disease is related to executive function, gender and age but not to depression","volume":"6","author":"Meyer","year":"2014","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.expneurol.2021.113716_bb0405","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cbi.2015.09.016","article-title":"N-palmitoyl serotonin alleviates scopolamine-induced memory impairment via regulation of cholinergic and antioxidant systems, and expression of BDNF and p-CREB in mice","volume":"242","author":"Min","year":"2015","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.expneurol.2021.113716_bb0410","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1017\/S1461145707008401","article-title":"Oxidative stress in psychiatric disorders: evidence base and therapeutic implications","volume":"11","author":"Ng","year":"2008","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.expneurol.2021.113716_bb0415","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.neuro.2013.12.004","article-title":"Vanadium exposure induces olfactory dysfunction in an animal model of metal neurotoxicity","volume":"43","author":"Ngwa","year":"2014","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.expneurol.2021.113716_bb0420","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s40035-018-0128-6","article-title":"Alpha-synuclein overexpression in the olfactory bulb initiates prodromal symptoms and pathology of Parkinson's disease","volume":"7","author":"Niu","year":"2018","journal-title":"Transl Neurodegener"},{"key":"10.1016\/j.expneurol.2021.113716_bb0425","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/brain\/aws358","article-title":"A progressive dopaminergic phenotype associated with neurotoxic conversion of alpha-synuclein in BAC-transgenic rats","volume":"136","author":"Nuber","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2021.113716_bb0430","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s40520-015-0380-x","article-title":"Olfaction deterioration in cognitive disorders in the elderly","volume":"28","author":"Ottaviano","year":"2016","journal-title":"Aging Clin. Exp. Res."},{"key":"10.1016\/j.expneurol.2021.113716_bb0435","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/mds.27344","article-title":"Treatment of autonomic dysfunction in Parkinson disease and other synucleinopathies","volume":"33","author":"Palma","year":"2018","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2021.113716_bb0440","doi-asserted-by":"crossref","first-page":"3646","DOI":"10.1007\/s12035-020-01947-w","article-title":"The impact of mitochondrial dysfunction on dopaminergic neurons in the olfactory bulb and odor detection","volume":"57","author":"Pass","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.expneurol.2021.113716_bb0445","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2147\/nedt.2007.3.1.145","article-title":"Prodromal non-motor symptoms of Parkinson\u2019s disease","volume":"3","author":"Pellicano","year":"2007","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.expneurol.2021.113716_bb0450","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0014-2999(79)90366-2","article-title":"Immobility induced by forced swimming in rats: effects of agents which modify central catecholamine and serotonin activity","volume":"57","author":"Porsolt","year":"1979","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2021.113716_bb0455","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/nrneurol.2016.152","article-title":"Advances in markers of prodromal Parkinson disease","volume":"12","author":"Postuma","year":"2016","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.expneurol.2021.113716_bb0460","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s12640-009-9087-0","article-title":"Single intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57BL\/6 mice models early preclinical phase of Parkinson\u2019s disease","volume":"17","author":"Prediger","year":"2010","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.expneurol.2021.113716_bb0465","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s00018-016-2367-y","article-title":"Determination of the connectivity of newborn neurons in mammalian olfactory circuits","volume":"74","author":"Ravi","year":"2017","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.expneurol.2021.113716_bb0470","doi-asserted-by":"crossref","first-page":"454696","DOI":"10.1155\/2014\/454696","article-title":"Adult hippocampal neurogenesis in Parkinson's disease: impact on neuronal survival and plasticity","volume":"2014","author":"Regensburger","year":"2014","journal-title":"Neural Plast."},{"key":"10.1016\/j.expneurol.2021.113716_bb0475","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/WCO.0000000000000348","article-title":"The nonmotor features of Parkinson\u2019s disease: pathophysiology and management advances","volume":"29","author":"Reichmann","year":"2016","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.expneurol.2021.113716_bb0480","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0114216","article-title":"Behavioral phenotyping of Parkin-deficient mice: looking for early preclinical features of Parkinson\u2019s disease","volume":"9","author":"Rial","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2021.113716_bb0485","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.pnpbp.2010.06.004","article-title":"Depressive-like behaviors alterations induced by intranigral MPTP, 6-OHDA, LPS and rotenone models of Parkinson\u2019s disease are predominantly associated with serotonin and dopamine","volume":"34","author":"Santiago","year":"2010","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.expneurol.2021.113716_bb0490","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nrn.2017.62","article-title":"Non-motor features of Parkinson disease","volume":"18","author":"Schapira","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.expneurol.2021.113716_bb0495","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s12640-009-9061-x","article-title":"Progressive dopaminergic degeneration in the chronic MPTPp mouse model of Parkinson\u2019s disease","volume":"16","author":"Schintu","year":"2009","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.expneurol.2021.113716_bb0500","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/jnr.23677","article-title":"Dopaminergic lesioning impairs adult hippocampal neurogenesis by distinct modification of alpha-synuclein","volume":"94","author":"Schlachetzki","year":"2016","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.expneurol.2021.113716_bb0505","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/7854_2014_317","article-title":"Clinical and pathological features of Parkinson\u2019s disease","volume":"22","author":"Schneider","year":"2015","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.expneurol.2021.113716_bb0510","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/mds.1099","article-title":"Comorbidity of the nonmotor symptoms of Parkinson\u2019s disease","volume":"16","author":"Shulman","year":"2001","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2021.113716_bb0515","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.pneurobio.2013.04.004","article-title":"Mitochondrial dysfunction and oxidative stress in Parkinson\u2019s disease","volume":"106-107","author":"Subramaniam","year":"2013","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.expneurol.2021.113716_bb0520","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ejphar.2008.07.005","article-title":"Mouse strain differences in immobility and sensitivity to fluvoxamine and desipramine in the forced swimming test: analysis of serotonin and noradrenaline transporter binding","volume":"592","author":"Sugimoto","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2021.113716_bb0525","doi-asserted-by":"crossref","first-page":"8103","DOI":"10.1523\/JNEUROSCI.1495-09.2009","article-title":"Nonmotor symptoms of Parkinson\u2019s disease revealed in an animal model with reduced monoamine storage capacity","volume":"29","author":"Taylor","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2021.113716_bb0530","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbr.2010.03.004","article-title":"Behavioral phenotyping of mouse models of Parkinson\u2019s disease","volume":"211","author":"Taylor","year":"2010","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.expneurol.2021.113716_bb0535","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.neuroscience.2015.10.021","article-title":"The impact of combined administration of paraquat and maneb on motor and non-motor functions in the rat","volume":"311","author":"Tinakoua","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2021.113716_bb0540","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0169-328X(00)00089-9","article-title":"Up-regulation of tyrosine hydroxylase mRNA in a sub-population of A10 dopamine neurons in Parkinson\u2019s disease","volume":"79","author":"Tong","year":"2000","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.expneurol.2021.113716_bb0545","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/bmb\/57.1.61","article-title":"Depresssion--emerging insights from neurobiology","volume":"57","author":"Vaidya","year":"2001","journal-title":"Br. Med. Bull."},{"key":"10.1016\/j.expneurol.2021.113716_bb0550","doi-asserted-by":"crossref","first-page":"624925","DOI":"10.1155\/2012\/624925","article-title":"Oxidative stress in genetic mouse models of Parkinson\u2019s disease","volume":"2012","author":"Varcin","year":"2012","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.expneurol.2021.113716_bb0555","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1586\/14737175.2015.1083423","article-title":"The relevance of pre-motor symptoms in Parkinson\u2019s disease","volume":"15","author":"Visanji","year":"2015","journal-title":"Expert. Rev. Neurother."},{"key":"10.1016\/j.expneurol.2021.113716_bb0560","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1097\/WNR.0b013e3282ffda5e","article-title":"Abnormal colonic motility in mice overexpressing human wild-type alpha-synuclein","volume":"19","author":"Wang","year":"2008","journal-title":"Neuroreport"},{"key":"10.1016\/j.expneurol.2021.113716_bb0565","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.neuro.2016.11.006","article-title":"Parkinson's disease-like motor and non-motor symptoms in rotenone-treated zebrafish","volume":"58","author":"Wang","year":"2017","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.expneurol.2021.113716_bb0570","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1471-4159.2004.02728.x","article-title":"Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson\u2019s disease","volume":"91","author":"Yamada","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2021.113716_bb0575","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000005400","article-title":"Nonmotor symptoms in patients with Parkinson disease: a cross-sectional observational study","volume":"95","author":"Zhang","year":"2016","journal-title":"Medicine"},{"key":"10.1016\/j.expneurol.2021.113716_bb0580","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.3892\/mmr.2016.5470","article-title":"Increased protein expression levels of pCREB, BDNF and SDF-1\/CXCR4 in the hippocampus may be associated with enhanced neurogenesis induced by environmental enrichment","volume":"14","author":"Zhang","year":"2016","journal-title":"Mol. Med. Rep."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488621001229?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488621001229?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T06:08:45Z","timestamp":1758002925000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488621001229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":116,"alternative-id":["S0014488621001229"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2021.113716","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of nonmotor behavioral impairments and their neurochemical mechanisms in the MitoPark mouse model of progressive neurodegeneration in Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2021.113716","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113716"}}